All Stories

  1. The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome

    Article • EMBO Molecular Medicine, September 2020, EMBO

    Anna Ehinger

  2. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Anna Ehinger

  3. Spatial Deconvolution of HER2-positive Breast Tumors Reveals Novel Intercellular Relationships

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  4. Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer

    Article • npj Breast Cancer, July 2020, Springer Science + Business Media

    Anna Ehinger

  5. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  6. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  7. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Article • npj Breast Cancer, May 2020, Springer Science + Business Media

    Khalid El Bairi, Anna Ehinger

  8. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    Article • The Journal of Pathology, April 2020, Wiley

    Anna Ehinger, Khalid El Bairi

  9. Pan-cancer analysis of whole genomes

    Article • Nature, February 2020, Springer Science + Business Media

    Taobo Hu, Anna Ehinger, Professor Daniel S. Brewer, Dr Elizabeth L Christie

  10. The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  11. Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer

    Article • PLoS ONE, December 2019, PLOS

    Anna Ehinger

  12. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

    Article • Nature Reports Stem Cells, September 2019, Springer Science + Business Media

    Anna Ehinger

  13. Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series

    Article • Scientific Reports, August 2019, Springer Science + Business Media

    Anna Ehinger

  14. Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

    Article • Breast Cancer Research and Treatment, August 2019, Springer Science + Business Media

    Anna Ehinger

  15. Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort

    Article • Clinical Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Anna Ehinger

  16. Refinement of breast cancer molecular classification by miRNA expression profiles

    Article • BMC Genomics, June 2019, Springer Science + Business Media

    Anna Ehinger

  17. Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration

    Article • Histopathology, April 2019, Wiley

    Anna Ehinger

  18. Stability of oestrogen and progesterone receptor antigenicity in formalin-fixed paraffin-embedded breast cancer tissue over time

    Article • August 2018, Wiley

    Anna Ehinger

  19. Multidimensional transcriptomics provides detailed information about immune cell distribution and identity in HER2+ breast tumors

    Article • June 2018, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  20. Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative

    Article • JCO Precision Oncology, March 2018, American Society of Clinical Oncology (ASCO)

    Anna Ehinger

  21. Abstract P1-06-01: Putting multigene signatures to the test: Prognostic assessment in population-based contemporary clinical breast cancer

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  22. Abstract P2-02-09: Breast cancer subtype distribution and circulating tumor DNA in response to neoadjuvant chemotherapy: Experiences from a preoperative cohort within SCAN-B

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  23. Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  24. Abstract P3-02-02: Concordance between immunohistochemical and gene-expression based subtyping of early breast cancer using core needle biopsies and surgical specimens - experices from SCAN-B

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  25. Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study

    Article • Cancer Research, February 2018, American Association for Cancer Research (AACR)

    Anna Ehinger

  26. Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative

    Article • British Journal of Surgery, January 2018, Wiley

    Anna Ehinger

  27. Abstract P1-07-17: The SCAN-B study: 5-year summary of a large-scale population-based prospective breast cancer translational genomics platform covering a wide geography of Sweden (NCT02306096)

    Article • Cancer Research, February 2017, American Association for Cancer Research (AACR)

    Anna Ehinger

  28. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013

    Article • Acta Oncologica, October 2016, Taylor & Francis

    Anna Ehinger

  29. Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer

    Article • PLoS ONE, March 2016, PLOS

    Anna Ehinger

  30. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy

    Article • European Journal of Cancer, November 2015, Elsevier

    Anna Ehinger

  31. Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing

    Article • August 2015, Springer Science + Business Media

    Anna Ehinger

  32. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

    Article • Genome Research, May 2015, Cold Spring Harbor Laboratory Press

    Anna Ehinger

  33. Abstract P6-08-43: Histological grade provides significant prognostic information in the discrimination between luminal A-like and luminal B-like HER-2 normal subtypes of breast cancer according to St Gallen 2013

    Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Anna Ehinger

  34. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine

    Article • Genome Medicine, January 2015, Springer Science + Business Media

    Anna Ehinger

  35. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Article • eLife, October 2014, eLife

    Professor Ming-Qing Du, Anna Ehinger, adrienne Flanagan, Professor Daniel S. Brewer

  36. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Article • Science, July 2014, American Association for the Advancement of Science

    Anna Ehinger, Professor Daniel S. Brewer

  37. Processed pseudogenes acquired somatically during cancer development

    Article • Nature Communications, April 2014, Nature

    Anna Ehinger

  38. Acute pancreatitis evoked by small-cell lung carcinoma metastases and detected by endoscopic ultrasound

    Article • Endoscopy, March 2012, Thieme Publishing Group

    Anna Ehinger

  39. The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

    Article • Journal of Ovarian Research, January 2012, Springer Science + Business Media

    Anna Ehinger

  40. G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua

    Article • Molecular Human Reproduction, May 2010, Oxford University Press (OUP)

    Anna Ehinger

  41. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

    Article • Breast Cancer Research and Treatment, January 2010, Springer Science + Business Media

    Anna Ehinger

  42. Histamine uptake by human endometrial cells expressing the organic cation transporter EMT and the vesicular monoamine transporter-2

    Article • Molecular Human Reproduction, June 2006, Oxford University Press (OUP)

    Anna Ehinger

  43. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle

    Article • Molecular Human Reproduction, July 2004, Oxford University Press (OUP)

    Anna Ehinger

  44. Paracrine Stimulation of Capillary Endothelial Cell Migration by Endometrial Tissue Involves Epidermal Growth Factor and Is Mediated Via Up-Regulation of the Urokinase Plasminogen Activator Receptor

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2001, Endocrine Society

    Anna Ehinger

  45. Breast metastases from pancreatic and ovarian carcinoma

    Article • Diagnostic Cytopathology, August 1999, Wiley

    Anna Ehinger